<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 306 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page305.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=306">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 306 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 306</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=306"><img src="../thumb/306.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.12                                                        2020-04 / 269
       reacts.with ritonavir, atazanavir./ lopinavir. & ritonavir combinat.  Contraindications: Mod.to sev.uncontrol.kidn. fail., pregn.& lactat  funct.in pts.with pre-exist.liv.dysfunct., cons.ther.interrupt./discont.
       and saquinavir & ritonavir combinat.incr.tenofovir conc., ethinyl   Side effects: Freq: Headache, dizzin., sleep disturbs., depress.dis-  if evid. of worsen.liv.dis., avoid in antiretrov.exper. pts. with HIV-1
       oestrad. AUC incr., rifampicin decr.efavirenz AUC & C max , ser.conc.  ord., N&V, diarrh., elev. amylase incl.elev. pancreat.amylase, elev.  harbour.K65R mutat., bone monit.in pts. with patholog.bone fract.
       of drugs elimin.by act.tubul.secret. may incr., meds.induc.CYP3A4   ser. lipase, abdom.pain, dyspeps., flatul., anorex., rash, neutropen.,   hist./osteopen.risk, Ca & vit.D supplementat.poss.benefic., incr.risk
       activ.(eg. phenobarbit./ rifampic.& rifabutin) incr.clear., incr. zidovu-  elev.creatin.kinase, elev. AST/ALT, hyperbilirubinaem., incr.transami-  for sev. hepat.adverse effs.in chron.hepatit.B or C co-infect., ref.to
       dine C max with lamivudine, incr.efavirenz expos. with atazanavir in   nases, hyperglycaem., hypertriglyceridaem., hypophosphataem., al-  PI of concom.hepat.B or C meds., exacerbat. of hepatit.incl.treatm.
       combin.with ritonavir.        lerg.react., pain, asthen. Less freq: Pancreatit., incr.ser.-amylase,   flares & flates aft. treatm. discont., limit.data in elderly &gt; 65 yrs., dis-
       ELTENO, (Activo) Macleods, [P/S]  incr. creatin., proteinur., ren.fail. (ac.& chron.), ac.tubul. necros.,   cont. ther.immed.if any hypersens.react.susp./ occurs.& init.appropr.
                                                                  ther., lact.intol., avoid if plan. pregn., reproduct.toxic.report., pregn.
                                     proxim.ren.tubulopathy incl.Fanconi syndr., nephrit., nephrogen.
       Tenofovir disoproxil fumarate 300 mg, efavirenz 600 mg, lamivu-  diabet.insipid., hepat. steatos., hepatit., angioed. Freq.unknown:   test in women of childbear. potent.bef.init./periodic.dur. treatm. &
       dine 300 mg.                  Neuropathy, paraesthes., periph.neurit./ neuropathy, asthen., anx.,   when pregn.suspect., lamivudine excret. in breast milk, monit.with
       Indications: HIV-1 infect.adults over 18 yrs.who have been   skin discolourat.on palms/ sole, myalg., arthralg., back/chest pain,   concom.co-trimoxazole, concom. ETR not recomm.unless receiv.con-
       treat.& stabil.on a combinat.of the above separate formulat.at   anaem., neutropen., haematur., incr.cough & rhinit., pneum., dyspn.,   com. ATV + RTV/ LPV + RTV or DRV + RTV, avoid concomit. cytidine
       simil.dosages.                hypokalaem., lact.acidos. assoc. with sev.hepatomeg.& steatos., hy-  analog.incl.emtricitabine, avoid concom.cladribine, admin.2 hrs.
       (S4) TABS, 49/20.2.8/0224     pertriglyceridaem., hyperglycaem., allergy, fev, sweat., weight loss,   bef./6 hrs.aft. polyval. cation-cont.antacids, admin.2 hrs.bef./ 6 hrs.
       723043-001: 28, R233,92       sev.ac.exacerbat.of hepatit.B aft. discont.  aft.Ca/Fe supplem.
       723043-002: 30, R241,50       Warnings and special precautions: Safety & effic. not est.in   Interactions: Conc.of isoniazid incr.by dolutegravir, lamivudine
       Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.may   hepatit. B vir.& HIV co-infects., monit. hepat.funct.for sev.mnths.if   poss.inhib.intracellul. phosphorylat. of zalcitabine, trimethoprim
       improv.CNS sympt. tolerabil.  discont.& pts. co-infect.with HIV & HBV, eval.for signs of fat redistrib.,   incr. lamivudine plasma lev., lamivudine incr.expos.& peak. plasma
       Contraindications: Safety & effic.not est.in co-infect. HBV & HIV   lev. of zidovudine, conc.of tenofovir /concom.med incr.with concom.
       pts., pregn.& lactat., mod-sev. ren. impairm., mod to sev.uncontrol.  CV risk assessm.in pts.with evid.of lipodystrophy, immune reconstit.  drugs elimin.by glomerul. & act.tubul.secret., tenofov.ser.conc.incr.
                                     inflamm.syndr., pts. to seek med.advice if exper.joint pain/aches/
       ren.fail., concom. meds/combinat.contain.Elteno act. ingred., con-  by agents decr.ren.funct., Cmax & AUC of didanosine incr., atazanavir
       com.adefovir dipivoxil, concom. astemizole/ bepridil/cisapride/mi-  stiffn./ movem.diffic.as osteonecros.poss., monit. BMD in pts.with   incr.tenofovir C max/ AUC/C min., lopinavir/ritonavir incr.tenofovir AUC/
                                     patholog.bone fract.hist./at risk of osteopen., opportunist.infects &
       dazolam/ pimozide/ triazolam, ergot derivat.or zalcitabine, concom.   C min., indinavir incr.tenofovir C max, saquinavir/ ritonavir incr.tenofovir
       St John’s Wort, concom.voriconazole, sev. hepat.impairm., safety &   other HIV complicat. still poss., ther.not proven to prev.HIV transmiss.   C min, tenofovir incr.C max of abacavir/indinavir, tenofovir incr.C max/
                                     through sex.cont./bld.contam., hepat. dis.risk fact., discont.if find.
       effic.in pts.less than 18 yrs. not est.                    AUC/Cmin of atazanavir/ saquinavir + ritonavir, poss.reduc.effic.
       Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.  suggest.lact.acidos./ hepatotoxic., investig.child.expos.in utero to   of cladribine, poss.decr.dolutegravir conc.with induc. of UGT1A3/
       fatal.with maj.of cases being women, sev.ac.exacerbat.of hepatit.B   nucleoside & nucleotide analog.for poss. mitochondr. dysfunct.in   UGT1A9/ CYP3A4/ Pgp/ BCRP, poss.incr. dolutegravir conc.with in-
       aft.discont., ren. impairm.incl.ac.ren.fail.& Fanconi syndr., ser. psych.   case of relev.S&S, consid. pancreatit.if pt.devel. abdom.pain/N&V/  hibits.of UGT1A3/ UGT1A9/ CYP3A4/ Pgp, signif.reduc. dolutegra-
       sympts.incl.sev.depress./suicid.ideat./ delus. & pyschos.-like behav.,   elev. biochemic. markers & discont.until diagnos.of pancreatit. excl.,   vir plasma conc.with tipranavir/ efavirenz/ nevirapine/rifampicin,
       CNS sympts.incl. hallucinat./abnorm.think.& depersonalisat.which   safety & effic.not est.in pts.with signific. underlying liv.disords./dis.,   reduc. dolutegravir plasma conc.with etravirine/ fosamprenavir,
       gen. improv.with cont.ther., convuls., pancreatit., rash, allerg.reacts.,   monit. liv. funct. in pts.with pre-exist.liv.dysfunct., pts.with chron.   rilpivirine incr.Cmax/AUC/C τ of  dolutegravir, poss.incr.metformin/
       gynaecomast., GI disturbs., body fat redistribut./accumulat., weight   hepatit. B/C treat.with antiretrovir.ther.are at incr. risk for sev.&   dofetilide/ pilsicainide plasma conc.with dolutegravir., poss. decr.
       gain/-loss, appetite incr., abnorm.co-ordinat., atax., hypoaesthes.,   potent.fatal hepat.adverse reacts., also consult prod.lit.of concom.  dolutegravir conc.with oxcarbazepine/ phenytoin/ phenobarb./
       paraesthes., neuralg., periph. neuropathy, speech disord., tremor, ver-  antiviral ther.for hepatit. B/C, imp.ren.funct., concom./rec. nephro-  carbamazepine/St John’s Wort though no studies, incr.dolutegra-
       tigo, syncope, abnorm.vis., tinnit., palpitat., tachycard., asthma, URTI,   tox. meds., concom.drugs contain lamivudine., concom.didanosine   vir plasma conc. with atazanavir/telaprevir, atazanavir + ritonavir,
       GI disturbs., hepatit., incr.hepat. enzym., hepat.fail., skin rash, incr.  & discont.if advers. effs.develop, recom.concom.atazanavir be ad-  decr.dolutegravir conc.with tipranavir + ritonavir/ fosamprenavir +
       swell., erythema multiforme, Stev.-John.syndr., alopec., skin exfo-  min. with ritonavir, concom.atazanavir & lopinavir/ritonavir, elderly.  ritonavir/Darunavir + ritonavir
       liat., urticar., nail disords., skin discolourat., acne, eczema, folliculos.,   Interactions: Conc.incr.with concom.drugs elim. by act.tubul.
       seborrh., photoallerg. dermatit., arthralg., myalg., myopathy, impot.,   secret., ser.conc.incr.by agents decr. ren.funct., C max of abacavir   EMTEN, (Activo) Emcure [P/S]
       incr./ decr.libido, fatig., asthen., hot flushes, malaise, influenza-like   incr.,C max & AUC of didanosine incr., atazanavir & lopinavir /ritona-  Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg
       sympts., pain, neutropen., anaem., thrombocytopen., pure red cell   vir incr. tenofovir conc.,AUC & C min of atazanavir decr., indinavir incr.   Indications: In combinat.with other antiretrovir. in adults with
       aplas., cough, nas.sympts., rhabdomyolys., hypertriglyceridaem.,   tenofovir C max, C max of lamivudine/ indinavir decr.  HIV-1 infect.
       hypercholesterolaem., insul. resist., hyperglycaem., hyperlacta-  EMDOLTEN, Aspen Pharmacare   (S4) TABS, 50/20.2.8/0243
       taem., inflamm. react. to asymptomat./resid.infects.in sev.immune   (Pharmacare) [P/S]  723717-001: 30, R477,04
       defic. when init.ther., osteonecros., hypophosphataem., haematur.,   Tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg, dolute-  Dosage: 1 tab.once dly.without regard to food.
       pneum., dyspn., osteomalac., fev., sweat., BMD decr.  gravir sod. 50 mg  Contraindications: Safety & effic.not est.in hepatit. B vir.co-in-
       Warnings and special precautions: Monit. hepat. funct.for   Indications: Treatm.of HIV infect.adults ≥ 18 yrs.  fects., chron.HBV infect., mod.to sev. uncontr.ren.impairm., pregn.&
       sev.mnths.in pts.co-infect.with HIV & HBV who discont.ther., init.  (S4) TABS, 53/20.2.8/0082  lactat., concom. drugs contain tenofovir/emtricitabine or lamivu-
       anti-hepatit.B ther.if appropr., liv.dis.risk fact., pre-exist.liv. dis./ dis-  3000580-001: 30, R234,60  dine, safety & effic.in paed.pts.&lt;18 yrs.not est., concom.atazana-
       ords., discont.if find.suggest. lact.acidos./ hepatotoxic., mitochondr.  Dosage: Consult.prod.info.of each therapeut. compon. of regim.bef.  vir without ritonavir.
       dysfunct.risk, pts.co-infected with HBV/C, test for chron.hepatit.B   init.treatm., init.ther.by physic. exper.in HIV infect.managem. Adults:   Side effects: Freq: Headache, dizzin, sleep disturbs., depress., GI
       bef. init.ther., determ.creatin.clear.bef.init.& dur.ther., avoid with   1 tab. once dly. Rifampicin decr.bld.lev.of dolutegravir & supplement.  disturbs., rash event neutropen., elev.creatin.kinase, elev.AST/ALT,
       concom./rec.nephrotox.agents, immed. risk vs.benefit eval.of cont.  dos.of dolutegravir poss.requir.  hyperbilirubinaem., incr.transaminas., hypertriglyceridaem., hyper-
       ther.when ser.psych. sympts.exper., bedt.dos.poss.improv.tol.of CNS   Contraindications: Ren.funct.impairm., pregn.& lactat., women   glycaem., hypophosphataem., pain, asthen. Less freq.: pancreatit.,
       effs., poss.addit.CNS effs.with concom.alcoh/ psychoact. meds.,   of child-bear.age not using highly effect.contracept., concom.ade-  ser.-amylase conc.rais., rhabdomyolys., musc.weakn., osteomalac.,
       seiz.hist., discont.if pancreatit. suspect.till diagn.excl., do not ad-  fovir dipivoxil/ dofetilide/ pilsicainide/didanosine/metformin, pts. &lt;   myopathy., anaem., incr.creatin., proteinur., ren. fail., ac.tubul.necros.,
       min.concom. saquinavir as sole protease inhibit., rash report. with   18 yrs., mod.to sev.liv funct.impairm.  proxim.ren.tubulopathy incl. Fanconi syndr, nephrit., nephrogen.dia-
       efavirenz & clarithromycin theref.consid.alt., barr. contracept.in ad-  Side effects: Freq: Insomn., abnorm.dreams, depress., headache,   bet.insipid., hepatit., hepat.steatos., chest pain, pneumon., dyspn.,
       dit.to OC’s recomm., monit.IV drug users for poss.withdr.when us-  dizzin., GI disords., rash, prurit., fatig., cough, nas.sympts, alopec.,   hypokalaem, allerg.react., angioed. Unknown: Neuropathy, periph.
       ing methadone, high dos.co-trimoxaz.in PCP & toxoplasmos.to be   arthralg., musc. disords./pain, malaise, fev., hypophosphataem., incr.  neurit., paraesthes., fev., sweat., weight loss, insomn., anx., abomin.
       avoid., teratogenic.with efavirenz, cont.adeq. contracept. x12 wks.  liv.enzymes, asthen. Less freq: Hypersens., IRIS, suic.ideat./attempt,   pain, hyperpigmentat.of palms &/ soles, arthralg., myalg, back pain,
       aft.discont., take miss.dos. when remembered unless there is less   hepatit., myalg., ren.impairm., neutropen., anaem., thrombocytopen.,   haematur., incr. cough, rhinit., lactic.acidos.& sev.hepatomegaly with
       than 12 hrs. bef.next dos., concom.didanosine not recomm., do not   pure red cell aplas., lact.acidos., lipodystrophy, metabol.abnorm.incl.   steatos.incl.fatal., sev.ac.exacerbat.of hepatit. B aft.discont., body fat
       admin. concom.atazanavir without ritonav., discont. ther.with sev.  hypertriglyceridaem./ hypercholesterolaem./ insulin resist/ hyper-  redistribut./ accumulat., BMD decr.from baseline, inflamm. respons.
       skin rash assoc.with blister./ desquamat./mucos.involvem.& fev.,   glycaem/hyperlactatem., periph. neuropathy, paraesthes., late onset   to indol./resid.infects.necessit.furth.eval. & treatm.
       consid. discont. other antiretrovir.to avoid drug resist.virus develop.  neurologic. disords.in childr.expos.in utero, convuls., pancreatit., elev.  Warnings and special precautions: No stud. demonstrat. eff.on
       if efavirenz discont., eval.risk vs.benef.of cont.ther.if ser.transami-  ser.amylase, decr.bone mineral dens., osteopen, fracture., myosit.,   clinic.progress.of HIV-1, obesity & prolong. nucleoside use poss.risk
       nase.lev.persist.5x&gt;ULN, monit. BMD in pts.with patholog.bone   angioed., hypokalaem., hepat.steatos., rhabdomyolys., musc.weakn.,   fact.for lact. acidos., liv.dis.risk fact., discont.if clin./lab.find. suggest.
       fract. hist./ at risk of osteopen., Ca & vit.D supplementat.poss be-  osteomalac., hyperton., myopathy, osteomalac., incr.creatin., ac. tu-  lact.acidos./pronounc.hepatotoxic., test for hepatit.B bef.init.ther.,
       nefic., adv.pts to seek medic.advice if exper. joint ache./pain/stiffn.  bul. necros., nephrit., nephrogen.diabet.insipid., proteinuria, polyuria.   monit.hepat.funct.for sev. mnths.if discont.& pts.co-infect.with HIV
       or movem.diffic., elderly, CV risk assessm.in pts.with liopdystr.,   Freq.unknown: Vertigo, neural tube defects in newborns of women   & HBV, Hepatit.C co-infect., if appropr.init.of anti-HBV ther.may be
       consid.monit. cholster./ triglycer.levs., immune reconstitut. inflam.   tak. dolutegravir at time of concept., hepatomegaly, hepat. steatos.,   warrant., thorough CV risk assessm. on evid.of lipodystrophy, im-
       syndr., opportunist.infects.& HIV complicat. may contin., prev.of risk   osteonecros, neutropen., allerg. reacts., lact.acidos., convuls., dyspn.  mune reconstit. syndr.,imp.ren.funct., liv.dysfunct., concom./ rec.
       of HIV transmiss.not proven, congenit. galactosaem./gluc.& galact.   Warnings and special precautions: Not indicat. for treatm of   nephrotox. agents, concom atazanavir must be admin.with ritona-
       malabsorpt./lactase defic.syndr.  chron.HBV infect., safety & effic. not est.in HBV & HIV co-infects.,   vir, concom. didanosine, monit.BMD in pts.with patholog.bone fract.
       Interactions: Ser.conc.of drugs elimin.by act. tubul. secret.may   monit. hepat.funct.for sev.mnths.in pts.co-infect.with HIV & HBV   hist./at risk of osteopen., osteonecros., Ca & vit. D supplementat.
       incr., plasma conc.of other compds. that are CYP3A4 substrat.poss.  who discont.ther.& appropr.init.of anti-hepatit. B ther.poss.necess.,   poss benefic., elderly., developm. of opportunist.infects.& other HIV
       decr., meds. induc.CYP3A4 activ.(eg.phenobarbit./ rifampic. & rifabu-  consult profess.info. of meds.used in combinat.bef.init.ther., eval.  complicat. may cont., ther.not prov.to prev.HIV transmiss. risk, rare
       tin) incr.clear., indinavir AUC & C trough decr., incr.clinic.adverse reacts.  for signs of fat redistrib., monit.fast.ser.lipids & bld. gluc. lev., CV   heredit probl./hist of galact. intol./ Lapp lact.defic./gluc.-galact. mal-
       with ritonavir, saquinavir AUC & C max decr., rifampicin decr. efavirenz   risk assessm.with evid.of lipodystrophy, immune reconstit.inflam.  absorpt., mitochrond. dysfunct.in HIV negat.infts.expos.in utero/ post
       AUC & C max  efavirenz has signific.eff.on clarithromyc. pharmacoki-  natally theref.clinic.& lab.follow-up recomm., consid.pancreatit.if
       net., methadone plasma conc. decr., reduc.efavirenz conc.with St   syndr., pts. to seek med.advice if experienc.joint pain/aches/ stiffn./   pt.dev. abdom.pain/ N&V/ elev.biochemic.mark & discont.until di-
                                     movem.diffic.as osteonecros.poss., opportunist. infects.& other HIV
       John’s Wort expect., atazanavir./lopinavir.&ritonavir combinat. incr.   agnos. of pancreatit.excl., ref.to prod.lit.when prescrib. other meds
       tenofovir conc., tenofovir decr. atazanavir/ atazanavir & ritonavir   complicat.may still devel., ARV ther.will not prev.transmiss.through   Interactions: Meds.that reduc.ren.funct./ compete for act.tubul.
                                     sex.cont.& bld.transfus.& appropr.precaut.to contin., discont.in pts.
       combinat./ indinav.& lamivudine pharmacokinet.paramet., signific.  secret.poss.incr.ser.conc.of either med, C max of abacavir incr., C max &
       clinic.change in didanosine pharmacokinet. with tenofovir., potent.  develop.clinic./lab.findings suggest.lact.acidos./hepatotox., pts.with   AUC of didanosine incr., tenofovir AUC/C max & C min incr. with con-
                                     hepatomegaly/ hepatit/other risk facts.for liv. dis./hepat.steatos.,
       addit.CNS effs.with alcoh.& psychoact.meds., plasma conc.of ator-  com.atazanavir, atazanavir AUC/C max& C min decr., tenofovir conc.
       vastatin/ pravastatin/simvastatin decr.  pts.co-infect.with hepatit.C & treat.with alpha interferon & ribava-  incr.with atazanavir & lopinavir/ ritonavir, decr.indinavir C max & incr.
                                     rin, eff.on clinic. progress.of HIV-1 not demonstrat., investig. childr.
       EMCOVIR, Emcure [P/S]         expos.in utero to nucleoside & nucleotide analog. for poss.mito-  tenofovir C max, decr. lamuvidine C max , tenofovir AUC& C min incr.with
                                                                  lopinavir& ritonavir combinat.
       Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg  chondr.dysfunct.in case of relev. S&S, discont.ther.until pancreatit.
       Indications: In combin.with other antiretrovir.in adults with HIV-  excl.in cases of N&V/abdom.pain/elev.biochem.mark., ren. funct.  EMTROC, (Activo) Macleods [P/S]
       1 infect.                     impairm., poss.incr.conc.of Emdolten &/ other ren.elimin.meds with   Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg
       (S4) TABS, 50/20.2.8/0242     meds.reduc.ren.funct./ compete for act.tubul.secret, monit.ren.funct.  Indications: In combinat.with other antiretrovir. in adults with HIV-1.
       723307-001: 30, R439,34       bef. init. ther & periodic.thereaft., avoid combin.with concurr./recent   (S4) TABS, 47/20.2.8/0188
       Dosage: 1 tab.once dly.without regard to food.  nephrotox./concom.meds.secret. by same ren.pathway, monit.liv.  721498-001: 30, R456,37</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page305.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page301.html">301</a>&nbsp;&nbsp;&nbsp;<a href="page302.html">302</a>&nbsp;&nbsp;&nbsp;<a href="page303.html">303</a>&nbsp;&nbsp;&nbsp;<a href="page304.html">304</a>&nbsp;&nbsp;&nbsp;<a href="page305.html">305</a>&nbsp;&nbsp;&nbsp;<a href="page306.html">306</a>&nbsp;&nbsp;&nbsp;<a href="page307.html">307</a>&nbsp;&nbsp;&nbsp;<a href="page308.html">308</a>&nbsp;&nbsp;&nbsp;<a href="page309.html">309</a>&nbsp;&nbsp;&nbsp;<a href="page310.html">310</a>&nbsp;&nbsp;&nbsp;<a href="page311.html">311</a>
             </td>
             <td width="35%"><a href="page307.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page307.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
